General

AI In The Drive-Thru: Chipotle, Starbucks, McDonald's Lead The Charge
What's Going On With Merck Stock On Monday?
FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse
What's Going On With Merck Stock On Monday?
FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse
What's Going On With Robinhood Markets Stock On Monday?
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment

General Recent News

Pete Buttigieg: 'Hurricane Beryl Is Proving To Be A Highly Destructive Storm'
AOC Says She Will File Articles Of Impeachment Against Supreme Court Justices After Trump Immunity Ruling: 'Assault On American Democracy'
Biden Slams Supreme Court Decision That Gives Partial Immunity To Trump: 'There Are No Kings In America'
One To The Right, One To The Left: France's National Rally Set For Record Win As The UK's Labour Party Regains Support
2024 global election cycle marks major shifts: France may turn far right, UK may shift left.
Investing In Football Isn't Just About What Happens On The Pitch
Private equity has had an increasing interest in sports and that shows no signs of slowing down.
Nvidia VP Simona Jankowski Joins Chip Startup Lightmatter As Finance Chief
Nvidia Vice President Simona Jankowski is joining Lightmatter Inc. as Chief Financial Officer. Jankowski, who spent nearly seven years at Nvidia, found a unique opportunity at Lightmatter, a startup leveraging silicon photonics to enhance AI computing.
Time To Cash Out? Analyst Recommends Tapping Into Meta As Prime Funding Source
Laura Martin of Needham reiterated Underperform rating on Meta Platforms, citing concerns from discussions with former employees and a social media ad agency CEO. The analyst notes that generative AI drives 20% of Meta's content generation and monetization, with plans to expand GPU investments.
CVS, Rite Aid, Walgreens Hit Hard By Online Pharmacy Trend
Rite Aid's restructuring plan, approved by a U.S. bankruptcy judge, reduces $2 billion in debt and shifts control to lenders. Following Chapter 11 bankruptcy and $750 million in losses, the pharmacy chain closed stores, sold Elixir, and settled opioid claims with most states.
Holding Onto Outdated Growing Methods? Commercial Growers Explains What It Takes To Outpace The Market
This article is part of Benzinga Cannabis' series ‘Cultivator Chronicles,' which focuses on the latest trends, developments, and major players in cannabis cultivation.
Is Shunned Shein The Future For Blockbuster China IPOs?
Key Takeaways: Shein may end up listing in Hong Kong, after its New York IPO plan collapsed and its latest London plan faces similar geopolitical pressures The case shows how blockbuster IPOs by Chinese firms are becoming more difficult in New York, though some major listings may still succeed By Doug Young
Chart Of The Week: The IRS Grabbed The Cannabis Stock Market's Attention
On Friday, June 28, 2024, Cannabis stocks were pounded by two different adverse events.
Chamath Palihapitiya Compares Biden's Efforts To Remain In Power To Warren Buffett, Slams People 'Diabolically' Propping President Up For A Second Term
Palihapitiya's comments come in the wake of Biden's disastrous debate performance against Trump.
Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract
Tonix Pharmaceuticals secures a potential $34 million agreement with the Defense Threat Reduction Agency to develop antiviral agents for military use. The program aims to enhance medical readiness against biological threats.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Brokers

Claim Exclusive Offers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers